Listeriosis Complicating Infliximab Treatment in Crohn's Disease
Journal Title: Journal of Clinical Gastroenterology and Treatment - Year 2016, Vol 2, Issue 2
Abstract
Listeria monocytogenes, a gram-positive rod, infects the central nervous system in neonates, pregnant woman and those immunosuppressed by naturally occurring illnesses and by therapeutic agents, including agents such as infliximab. We report here the first published case of Listeriosis complicating Infliximab therapy in Crohn's disease in Australia.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP343672
- DOI 10.23937/2469-584X/1510024
- Views 161
- Downloads 0
Minimal Change Nephrotic Syndrome and Hodgkin's Lymphoma Associated with Adalimumab Therapy
Anti-TNF-α medications have become a mainstay of treatment of moderate to severe symptoms of diseases including inflammatory bowel disease, ankylosing spondylitis, psoriasis and arthritis. There are many well-known adver...
Esophago-Pulmonary Fistula Caused by Lung Cancer Treated with a Covered Self-Expandable Metallic Stent
A 71-year-old man was diagnosed with squamous cell lung cancer in the right lower lobe. He was treated with chemotherapy (first line: TS-1/CDDP; second line: carboplatin/nab-paclitaxel) and radiation therapy (41.4 Gy), b...
Unusual Mixed Presentations of Multiple Jejunal Diverticulae with Small Bowel Obstruction and Perforation - Case Report
Jejunal diverticulae are a rare phenomenon that is usually asymptomatic but can present with chronic abdominal pain or as an acute abdomen when complicated by intestinal diverticulitis, obstruction, haemorrhage or perfor...
Utilization and Accuracy of Biopsy in Patients with Hepatocellular Carcinoma in a Community based Setting
Background and aim: Liver biopsy is not routinely recommended for the diagnosis of hepatocellular carcinoma (HCC). Identification of characteristic imaging findings is usually sufficient for diagnosis and biopsy is recom...
Advances and Controversies in the Management of Locally Advanced Gastro-esophageal Adenocarcinoma
Esophageal adenocarcinoma (EAD) has been recently described as ‘the silent epidemic’ because of its rapidly rising incidence. Two-thirds of patients with esophageal adenocarcinoma present with locally advanced disease. I...